Japan · Delayed Price · Currency is JPY Olympus Company Description
Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania.
It operates through two segments, “Gastrointestinal Solutions and Surgical & Interventional Solutions.
The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services.
The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products.
It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat.
The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003.
Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.
| Country | Japan |
| Founded | 1919 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 29,297 |
| CEO | Robert John White |
Contact Details
Address: 2951 Ishikawa-machi Hachioji, 192-8507 Japan | |
| Phone | 81 42 642 2111 |
| Website | olympus.co.jp |
Stock Details
| Ticker Symbol | 7733 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3201200007 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Robert John White | Chief Executive Officer |
| Michael Parenti | Chief Financial Officer |
| Takaaki Sakurai | Head of Investor Relations |